Mia's Feed
Medical News & Research

N-NAIL Score Demonstrates Greater Accuracy than NAPSI in Diagnosing Nail Psoriasis

N-NAIL Score Demonstrates Greater Accuracy than NAPSI in Diagnosing Nail Psoriasis

Share this article

A recent study reveals that the N-NAIL score outperforms NAPSI in accurately diagnosing nail psoriasis, offering a simpler and more reliable tool for clinicians and researchers.

2 min read

Recent research published in the International Journal of Dermatology highlights the superior diagnostic performance of the Nijmegen-Nail Psoriasis Activity Index Tool (N-NAIL) compared to the Nail Psoriasis Severity Index (NAPSI) for identifying nail psoriasis. Both scoring systems are used to evaluate the severity of nail involvement in psoriasis patients, but findings show that N-NAIL offers improved accuracy and simplicity.

The study, led by Dr. Evi C.C. Rikken from Radboud University Medical Center in Nijmegen, involved a cohort of 104 patients with psoriasis, of whom 68 had confirmed nail psoriasis. Researchers established optimal cutoff points for each scoring tool to determine their diagnostic efficacy. The N-NAIL, with a cutoff value of 2, achieved a sensitivity of 83.8% and specificity of 83.3% in diagnosing nail psoriasis among the psoriasis population. Similarly, in the general population, this cutoff maintained high sensitivity (83.8%) but a slightly lower specificity (67.3%).

In comparison, the NAPSI showed its best performance at a cutoff of 7 for patients with psoriasis, with a sensitivity of 80.9% and specificity of 69.4%. In the broader population, a cutoff of 10 was optimal, yielding a sensitivity of 72.1% and specificity of 70.2%.

The authors emphasized that the N-NAIL’s streamlined single-version scoring system makes it easier and quicker for dermatologists and researchers to apply, reducing confusion and facilitating more efficient diagnosis. The study underlines that the N-NAIL's higher accuracy and ease of use make it a preferable choice over NAPSI for clinical and research purposes.

For more details, refer to the original study: Evi C. C. Rikken et al., "What Is the Diagnostic Capacity of Existing Severity Scoring Tools for Nail Psoriasis?", International Journal of Dermatology (2025). [DOI: 10.1111/ijd.70024]

Source: https://medicalxpress.com/news/2025-08-score-accurate-napsi-psoriasis.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Potential Impact of GLP-1 Receptor Agonists on Diabetic Retinopathy Incidence and Outcomes

New research reveals that GLP-1 receptor agonists may slightly increase diabetic retinopathy incidence but could reduce severe eye complications, emphasizing the importance of regular eye screening for diabetics.

GLP-1 Receptor Agonists Associated with Reduced Mortality in Elderly Cancer Patients with T2D

A recent study shows that GLP-1 receptor agonists are associated with lower mortality rates in elderly cancer patients with type 2 diabetes, offering promising survival benefits in this vulnerable population.

Advances in Genetic Research Offer New Strategies for Early Blood Cancer Detection

New genetic research reveals how inherited and acquired mutations interact to influence blood cancer risk, opening avenues for early detection and prevention strategies.